Identification of Treatment Targets in a Genetic Mouse Model of Voluntary Methamphetamine Drinking - PubMed

Review

Identification of Treatment Targets in a Genetic Mouse Model of Voluntary Methamphetamine Drinking

T J Phillips et al. Int Rev Neurobiol. 2016.

Abstract

Methamphetamine has powerful stimulant and euphoric effects that are experienced as rewarding and encourage use. Methamphetamine addiction is associated with debilitating illnesses, destroyed relationships, child neglect, violence, and crime; but after many years of research, broadly effective medications have not been identified. Individual differences that may impact not only risk for developing a methamphetamine use disorder but also affect treatment response have not been fully considered. Human studies have identified candidate genes that may be relevant, but lack of control over drug history, the common use or coabuse of multiple addictive drugs, and restrictions on the types of data that can be collected in humans are barriers to progress. To overcome some of these issues, a genetic animal model comprised of lines of mice selectively bred for high and low voluntary methamphetamine intake was developed to identify risk and protective alleles for methamphetamine consumption, and identify therapeutic targets. The mu opioid receptor gene was supported as a target for genes within a top-ranked transcription factor network associated with level of methamphetamine intake. In addition, mice that consume high levels of methamphetamine were found to possess a nonfunctional form of the trace amine-associated receptor 1 (TAAR1). The Taar1 gene is within a mouse chromosome 10 quantitative trait locus for methamphetamine consumption, and TAAR1 function determines sensitivity to aversive effects of methamphetamine that may curb intake. The genes, gene interaction partners, and protein products identified in this genetic mouse model represent treatment target candidates for methamphetamine addiction.

Keywords: Addiction; Aversion; Medication; Polymorphism; Quantitative trait locus; Reward; Selected lines; Therapeutic.

Similar articles

• An animal model of differential genetic risk for methamphetamine intake.

  Phillips TJ, Shabani S. Phillips TJ, et al. Front Neurosci. 2015 Sep 23;9:327. doi: 10.3389/fnins.2015.00327. eCollection 2015. Front Neurosci. 2015. PMID: 26441502 Free PMC article. Review.

• Trace Amine-Associated Receptor 1 Regulation of Methamphetamine Intake and Related Traits.

  Harkness JH, Shi X, Janowsky A, Phillips TJ. Harkness JH, et al. Neuropsychopharmacology. 2015 Aug;40(9):2175-84. doi: 10.1038/npp.2015.61. Epub 2015 Mar 5. Neuropsychopharmacology. 2015. PMID: 25740289 Free PMC article.

• Responsible Controlled Substance and Opioid Prescribing.

  Horn DB, Vu L, Porter BR, Sarantopoulos K. Horn DB, et al. 2024 Dec 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Dec 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 34283451 Free Books & Documents.

• Confirmation of a Causal Taar1 Allelic Variant in Addiction-Relevant Methamphetamine Behaviors.

  Phillips TJ, Roy T, Aldrich SJ, Baba H, Erk J, Mootz JRK, Reed C, Chesler EJ. Phillips TJ, et al. Front Psychiatry. 2021 Aug 26;12:725839. doi: 10.3389/fpsyt.2021.725839. eCollection 2021. Front Psychiatry. 2021. PMID: 34512422 Free PMC article.

• The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review.

  O'Leary C, Ralphs R, Stevenson J, Smith A, Harrison J, Kiss Z, Armitage H. O'Leary C, et al. Campbell Syst Rev. 2024 Apr 21;20(2):e1396. doi: 10.1002/cl2.1396. eCollection 2024 Jun. Campbell Syst Rev. 2024. PMID: 38645303 Free PMC article. Review.

Cited by

• Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing.

  Modestino EJ, Blum K, Dennen CA, Downs BW, Bagchi D, Llanos-Gomez L, Elman I, Baron D, Thanos PK, Badgaiyan RD, Braverman ER, Gupta A, Gold MS, Bowirrat A. Modestino EJ, et al. J Pers Med. 2022 Nov 23;12(12):1946. doi: 10.3390/jpm12121946. J Pers Med. 2022. PMID: 36556167 Free PMC article.

• A Spontaneous Mutation in Taar1 Impacts Methamphetamine-Related Traits Exclusively in DBA/2 Mice from a Single Vendor.

  Reed C, Baba H, Zhu Z, Erk J, Mootz JR, Varra NM, Williams RW, Phillips TJ. Reed C, et al. Front Pharmacol. 2018 Jan 22;8:993. doi: 10.3389/fphar.2017.00993. eCollection 2017. Front Pharmacol. 2018. PMID: 29403379 Free PMC article.

• Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the Ugly.

  Szumlinski KK, Lominac KD, Campbell RR, Cohen M, Fultz EK, Brown CN, Miller BW, Quadir SG, Martin D, Thompson AB, von Jonquieres G, Klugmann M, Phillips TJ, Kippin TE. Szumlinski KK, et al. Biol Psychiatry. 2017 Jun 1;81(11):959-970. doi: 10.1016/j.biopsych.2016.10.005. Epub 2016 Oct 13. Biol Psychiatry. 2017. PMID: 27890469 Free PMC article.

• Voluntary inhalation of methamphetamine: a novel strategy for studying intake non-invasively.

  Juarez-Portilla C, Kim RD, Robotham M, Tariq M, Pitter M, LeSauter J, Silver R. Juarez-Portilla C, et al. Psychopharmacology (Berl). 2017 Mar;234(5):739-747. doi: 10.1007/s00213-016-4510-8. Epub 2016 Dec 27. Psychopharmacology (Berl). 2017. PMID: 28028601

• ERK-Directed Phosphorylation of mGlu5 Gates Methamphetamine Reward and Reinforcement in Mouse.

  Fultz EK, Quadir SG, Martin D, Flaherty DM, Worley PF, Kippin TE, Szumlinski KK. Fultz EK, et al. Int J Mol Sci. 2021 Feb 2;22(3):1473. doi: 10.3390/ijms22031473. Int J Mol Sci. 2021. PMID: 33540617 Free PMC article.

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program